4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000008
Chief Executive Officer sold 162,500 shares at an average $14.71 ($2,390,000)
- Chief Executive Officer acquired 62,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Sale : show line 1 in the form | −100,000 | $15.00 | $1,500,000 | 1,078,313 | D |
| 2021-02-03 | Exercise or conversion : show line 2 in the form | +62,500 | $4.56 | $285,000 | 1,140,813 | D |
| 2021-02-03 | Sale : show line 3 in the form | −62,500 | $14.24 | $890,000 | 1,078,313 | D |
| Open-market sales · 162,500 sh · avg $14.71 · $2,390,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-03 | Exercise or conversion : show line 4 in the form Common Stock Option | −62,500 | 0 | D |
Loading xslF345X03/wf-form4_161239761257738.xml…